Effects of the contraceptive vaginal ring, the contraceptive transdermal patch and combined oral contraceptives on markers of hemostasis
van Vliet, H.A.A.M.; Rosendaal, F.R.; Fleischer, K.; Rosing, J.; Helmerhorst, F.M.
Contraception 81(1): 88-9; author reply 89-90
2010
ISSN/ISBN: 0010-7824 PMID: 20004280 DOI: 10.1016/j.contraception.2009.05.131Document Number: 208456
Document emailed within 0-6 h
Related Documents
Meyer, S. 2009: Contraceptive patch and vaginal ring vs. combined oral contraceptives American Family Physician 80(3): 232Merz, M.; Kroll, R.; Lynen, R.; Bangerter, K. 2015: Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study Contraception 91(2): 113-120
Weisberg, E.; Merki-Feld, G.S.; McGeechan, K.; Fraser, I.S. 2015: Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen Contraception 91(2): 121-126
Boonyarangkul, A.; Taneepanichskul, S. 2007: Comparison of cycle control and side effects between transdermal contraceptive patch and an oral contraceptive in women older than 35 years Journal of the Medical Association of Thailand 90(9): 1715-1719
Audet, M.C.; Moreau, M.; Koltun, W.D.; Waldbaum, A.S.; Shangold, G.; Fisher, A.C.; Creasy, G.W. 2001: Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial JAMA 285(18): 2347-2354
Jensen, J.T.; Archer, D.F.; Westhoff, C.L.; Nelson, A.L.; Graham, S.; Bernick, B. 2023: Satisfaction with a Segesterone Acetate and Ethinyl Estradiol Contraceptive Vaginal System Among Recent Oral Contraceptive or Hormonal Contraceptive Vaginal Ring Users Journal of Women's Health 32(7): 808-815
Lopez, L.M.; Grimes, D.A.; Gallo, M.F.; Schulz, K.F. 2008: Skin patch and vaginal ring versus combined oral contraceptives for contraception Cochrane Database of Systematic Reviews 1: Cd003552
2013: Thrombotic risk of contraceptive transdermal patches and the contraceptive vaginal ring Prescrire International 22(143): 266 268-9
Thomas, R.L.; Halvorson, L.M.; Carr, B.R.; Doody, K.M.; Doody, K.J. 2013: Efficacy of combined contraceptive vaginal ring versus oral contraceptive pills in achieving hypothalamic-pituitary-ovarian axis suppression in egg donor in vitro fertilization cycles Journal of Reproduction and Infertility 14(4): 207-213
Duijkers, I.; Killick, S.; Bigrigg, A.; Dieben, T.O.M. 2004: A comparative study on the effects of a contraceptive vaginal ring NuvaRing and an oral contraceptive on carbohydrate metabolism and adrenal and thyroid function European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 9(3): 131-140
Law, A.; Lee, Y.-C.; Gorritz, M.; Plouffe, L. 2014: Does switching contraceptive from oral to a patch or vaginal ring change the likelihood of timely prescription refill? Contraception 90(2): 188-194
Konstantinus, I.N.; Balle, C.; Jaumdally, S.Z.; Galmieldien, H.; Pidwell, T.; Masson, L.; Tanko, R.F.; Happel, A.-U.; Sinkala, M.; Myer, L.; Bosinger, S.E.; Gill, K.; Bekker, L.-G.; Jaspan, H.B.; Passmore, J.-A.S. 2020: Impact of Hormonal Contraceptives on Cervical T-helper 17 Phenotype and Function in Adolescents: Results from a Randomized, Crossover Study Comparing Long-acting Injectable Norethisterone Oenanthate (NET-EN), Combined Oral Contraceptive Pills, and Combined Contraceptive Vaginal Rings Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 71(7): E76-E87
Swica, Y. 2007: The transdermal patch and the vaginal ring: two novel methods of combined hormonal contraception Obstetrics and Gynecology Clinics of North America 34(1): 31-42 Viii
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives : levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception (Stoneham) 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292